Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danziger is a global leader in the breeding, production, and commercialization of bedding plants, cut flowers, annuals, perennials, and foliage. The company has developed genetically engineered varieties of ornamental plants such as Gypsophila paniculata ("Baby's Breath") for commercial distribution. Their activities are focused on horticultural innovation rather than pharmaceutical or therapeutic product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danziger.